Related Experiment Video

Updated: Nov 18, 2025

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
09:58

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

3.0K

Decoding the function of an oncogenic transcription factor: finding the first responders

Chao Lu1

  • 1Department of Genetics and Development and Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.

Molecular Cell
|February 5, 2021
PubMed

Insights

Researchers identified key genes controlled by the AML1-ETO fusion protein, a crucial factor in acute myeloid leukemia (AML). This study advances understanding of how this oncogenic transcription factor drives disease.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • Transcription factors (TFs) play critical roles in cellular processes and are often dysregulated in diseases.
  • Understanding the direct targets of TFs is essential for elucidating their role in disease pathophysiology.
  • The AML1-ETO fusion protein is a common oncogenic driver in acute myeloid leukemia (AML).

Purpose of the Study:

  • To identify the core set of direct target genes regulated by the AML1-ETO oncogenic transcription factor.
  • To elucidate the molecular mechanisms underlying AML pathogenesis driven by AML1-ETO.

Main Methods:

  • Application of chemogenetic techniques to control AML1-ETO activity.
  • Utilizing nascent transcriptome mapping (e.g., 4sU-seq) to capture newly synthesized RNA.
  • Integration of these methods to precisely map TF-regulated genes in real-time.

Main Results:

  • Defined a core gene set directly and immediately regulated by the AML1-ETO fusion protein.
  • Identified specific transcriptional programs initiated by AML1-ETO.
  • Provided a high-resolution map of AML1-ETO's direct transcriptional targets.

Conclusions:

  • The study successfully identified the direct targets of the AML1-ETO oncogenic transcription factor.
  • This provides a foundation for understanding AML pathogenesis and developing targeted therapies.
  • The methodologies employed offer a powerful approach for studying TF function in disease.

More Related Videos

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

7.2K
Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

8.5K

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.8K
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
80.8K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.1K
Signal Transduction: Overview01:26

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
10.4K